Searched for
THERAPEUTIC CLAIMS
Sir H.N. Reliance Foundation Hospital Claims Top Spot In Nationwide Critical Care SurveySir H.N. Reliance Foundation Hospital has been ranked the country's leading multi-specialty institution in the Times of India Critical Care...
Psychology says older adults who garden almost every day aren’t just passing time: They are often building small loops of restoration, structure, and self-worthEngaging in gardening offers older adults a wealth of mental and physical benefits. Research indicates it enhances their outlook on aging b...
Stocks in news: RIL, Coal India, IDFC First Bank, Zydus Life, ONGCMarkets traded subdued with the India VIX correcting nearly 15% this week, though this hasn't significantly impacted benchmark index moveme...
Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
WHO chief concerned about 'scale and speed' of deadly Ebola outbreakThe World Health Organization has declared an international health emergency over an Ebola outbreak in the Democratic Republic of Congo. Th...
Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on toHolding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...
Drug regulator oversight sought for nutraceuticals; NGO flags quality, pricing concernsA Gujarat NGO is pushing the government to regulate nutraceuticals like medicines. They cite concerns about product quality and unregulated...
Cathie Wood vs Michael Burry: The $11 million Palantir bet that’s splitting Wall StreetCathie Wood bought $11 million worth of Palantir Technologies shares, boosting ARK ETFs’ holdings to over ₹283 crore, even as Michael Burry...
Patent rejected for MNC’s cancer drug; generics likely to enter marketThe Indian Patent Office has rejected a patent application for AbbVie's cancer drug Venetoclax. The office cited a lack of inventive steps ...
Major Australian sunscreens fail to deliver promised protection, study claims; check which brands are goodA recent investigation by CHOICE reveals that a significant number of popular sunscreens in Australia fail to meet their labeled SPF claims...
Software-as-a-service startup Spry Therapeutics secures $15 millionSpry Therapeutics, which focuses on building software for physical healthcare centres, is looking to ride the wave of software companies bu...
Dr Reddy's settles patent litigation with Indivior, Aquestive TherapeuticsThe stipulation of dismissal was filed pursuant to a settlement agreement that the company entered into with Indivior and Aquestive, it add...
Cellogen to bring next-gen cancer therapy to India"Chimeric Antigen Receptor cells represent a cutting-edge technology that holds great promise for cancer treatment. We are delighted to off...
Suven Life secures product patent in JapanSuven Life said it has been granted "one process patent from Japan corresponding to the NCEs which are for the treatment of disorders assoc...
- Supreme Court questions Novartis' patent claim on Glivec
Novartis appeared to suffer a setback in the Supreme Court in its attempt to obtain a patent for its anti-leukemia drug Glivec when the cou...
- Suven receives two product patents associated with Neurodegenerative
Suven Life Sciences has received two product patents in Eurasia for two new chemical entities for the treatment of disorders associated wit...
- Interpreting 'enhancement of known efficacy'
It would be worth watching how Indian patent authorities interpret the term “enhancement of known efficacy” that figures in the country’s P...